Literature DB >> 30403941

HSD17B13 and Chronic Liver Disease in Blacks and Hispanics.

Julia Kozlitina1, Stefan Stender2, Helen H Hobbs3, Jonathan C Cohen4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30403941     DOI： 10.1056/NEJMc1804027

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  13 in total

Review 1.  Exome Sequencing in Clinical Hepatology.

Authors:  Sílvia Vilarinho; Pramod K Mistry
Journal:  Hepatology       Date:  2019-12       Impact factor: 17.425

Review 2.  Advances in pediatric non-alcoholic fatty liver disease: From genetics to lipidomics.

Authors:  Simona Riccio; Rosa Melone; Caterina Vitulano; Pierfrancesco Guida; Ivan Maddaluno; Stefano Guarino; Pierluigi Marzuillo; Emanuele Miraglia Del Giudice; Anna Di Sessa
Journal:  World J Clin Pediatr       Date:  2022-03-23

3.  Loss of immunity-related GTPase GM4951 leads to nonalcoholic fatty liver disease without obesity.

Authors:  Zhao Zhang; Yu Xun; Shunxing Rong; Lijuan Yan; Jeffrey A SoRelle; Xiaohong Li; Miao Tang; Katie Keller; Sara Ludwig; Eva Marie Y Moresco; Bruce Beutler
Journal:  Nat Commun       Date:  2022-07-16       Impact factor: 17.694

4.  Characterization of essential domains in HSD17B13 for cellular localization and enzymatic activity.

Authors:  Yanling Ma; Suman Karki; Philip M Brown; Dennis D Lin; Maren C Podszun; Wenchang Zhou; Olga V Belyaeva; Natalia Y Kedishvili; Yaron Rotman
Journal:  J Lipid Res       Date:  2020-09-24       Impact factor: 5.922

5.  A closer look at the mysterious HSD17B13.

Authors:  X Charlie Dong
Journal:  J Lipid Res       Date:  2020-10-02       Impact factor: 5.922

6.  Genetic Susceptibility to Chronic Liver Disease in Individuals from Pakistan.

Authors:  Asad Mehmood Raja; Ester Ciociola; Imran Nazir Ahmad; Faisal Saud Dar; Syed Muhammad Saqlan Naqvi; Muhammad Moaeen-Ud-Din; Ghazala Kaukab Raja; Stefano Romeo; Rosellina Margherita Mancina
Journal:  Int J Mol Sci       Date:  2020-05-18       Impact factor: 5.923

Review 7.  PNPLA3-A Potential Therapeutic Target for Personalized Treatment of Chronic Liver Disease.

Authors:  Xiaocheng Charlie Dong
Journal:  Front Med (Lausanne)       Date:  2019-12-17

8.  17-Beta Hydroxysteroid Dehydrogenase 13 Deficiency Does Not Protect Mice From Obesogenic Diet Injury.

Authors:  Yanling Ma; Philip M Brown; Dennis D Lin; Jing Ma; Dechun Feng; Olga V Belyaeva; Maren C Podszun; Jason Roszik; Joselyn N Allen; Regina Umarova; David E Kleiner; Natalia Y Kedishvili; Oksana Gavrilova; Bin Gao; Yaron Rotman
Journal:  Hepatology       Date:  2021-03-16       Impact factor: 17.298

9.  Validating a non-invasive, ALT-based non-alcoholic fatty liver phenotype in the million veteran program.

Authors:  Marina Serper; Marijana Vujkovic; David E Kaplan; Rotonya M Carr; Kyung Min Lee; Qing Shao; Donald R Miller; Peter D Reaven; Lawrence S Phillips; Christopher J O'Donnell; James B Meigs; Peter W F Wilson; Rachel Vickers-Smith; Henry R Kranzler; Amy C Justice; John M Gaziano; Sumitra Muralidhar; Saiju Pyarajan; Scott L DuVall; Themistocles L Assimes; Jennifer S Lee; Philip S Tsao; Daniel J Rader; Scott M Damrauer; Julie A Lynch; Danish Saleheen; Benjamin F Voight; Kyong-Mi Chang
Journal:  PLoS One       Date:  2020-08-25       Impact factor: 3.240

Review 10.  Metabolic drivers of non-alcoholic fatty liver disease.

Authors:  Kendra K Bence; Morris J Birnbaum
Journal:  Mol Metab       Date:  2020-12-17       Impact factor: 7.422
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.